重药控股：主营业务为药品及医疗器械的批发与零售

Core Viewpoint - The company emphasizes its focus on improving cash flow management and enhancing research and development capabilities to address challenges in the pharmaceutical distribution industry [1] Group 1: Business Operations - The company operates in the pharmaceutical distribution industry, primarily engaged in the wholesale and retail of drugs and medical devices [1] - Recent efforts have been made to strengthen the collection of accounts receivable through enhanced assessment and collection measures [1] Group 2: Financial Management - The company has implemented measures to improve cash flow from operating activities, including better procurement management and continuous enhancement of credit management [1] Group 3: Research and Development - The company is increasing investment in research and development by introducing professional talent, deepening industry-academia-research cooperation, and optimizing R&D processes [1] - Continuous progress in new product development is being pursued to address issues related to R&D investment and capabilities [1]